Virtu KCG Holdings
ESPR icon

Virtu KCG Holdings’s Esperion Therapeutics ESPR Stock Holding History

Virtu KCG Holdings’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$419K Sell
9,047
-30,149
-77% -$1.11M 0.01% 1313
2017
Q1 		$1.38M Buy
+39,196
New +$898K 0.04% 480
2016
Q3 		– Sell
-41,780
Closed -$413K – 3167
2016
Q2 		$413K Buy
+41,780
New +$692K 0.01% 1558
2016
Q1 		– Sell
-10,296
Closed -$229K – 3040
2015
Q4 		$229K Sell
10,296
-14,904
-59% -$376K ﹤0.01% 2523
2015
Q3 		$594K Buy
+25,200
New +$1.58M 0.01% 1361

Other funds holding ESPR

Pentwater Capital Management
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Discovery Capital Management
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu KCG Holdings's ESPR Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Esperion Therapeutics (ESPR) stake by 77% in Q2 2017, selling an estimated $1.11M and leaving 9,047 shares worth $419K. The position accounts for 0.01% of the portfolio, ranked #1313.

Virtu KCG Holdings first reported a position in ESPR in Q3 2015 and has held it in 5 quarters since. The position peaked at $1.38M in Q1 2017. 131 funds tracked by Wall St. Rank hold ESPR as of Q2 2017.

  • Virtu KCG Holdings held 9,047 shares of Esperion Therapeutics worth $419K as of Q2 2017.
  • Virtu KCG Holdings sold 30,149 Esperion Therapeutics shares in Q2 2017, an estimated $1.11M.
  • Esperion Therapeutics made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1313 holding.
  • Virtu KCG Holdings first reported a position in Esperion Therapeutics in Q3 2015 and has held it in 5 quarters since.
  • Virtu KCG Holdings's Esperion Therapeutics position peaked at $1.38M in Q1 2017.
  • 131 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.